Valuation: Artrya Limited

Market Cap 535M 381M 330M 312M 284M 531M 36.57B 3.73B 1.44B 18.55B 1.43B 1.4B 59.13B P/E 2027 *
-22.1x
P/E 2028 * -41.8x
Enterprise Value 480M 342M 297M 280M 254M 477M 32.83B 3.35B 1.29B 16.65B 1.29B 1.26B 53.07B EV / Sales 2027 *
87.2x
EV / Sales 2028 * 23x
Free-Float
81.76%
Yield 2027 *
-
Yield 2028 * -
1 day+9.15%
1 week+10.15%
Current month-15.57%
1 month-27.68%
3 months-23.67%
6 months+16.23%
Current year-23.99%
1 week 3.02
Extreme 3.02
3.59
1 month 3.02
Extreme 3.02
5.19
Current year 2.55
Extreme 2.55
6.49
1 year 2.12
Extreme 2.12
6.49
3 years 0.16
Extreme 0.16
6.49
5 years 0.16
Extreme 0.16
6.49
10 years 0.16
Extreme 0.16
6.49
Manager TitleAgeSince
Chief Executive Officer - 2025-06-30
Director of Finance/CFO - 2026-08-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 72 2021-01-31
Director/Board Member 71 2022-07-31
Director/Board Member 67 2023-02-21
Date Insider Type Main position Quantity % Market Cap. Importance
7/10/26 Expiration

Chairman

-750,000 0.4602%
4/14/26 Exercice

Chairman

500,000 0.3163%
4/14/26 Exercice

Chairman

500,000 0.3163%
Change 5-day change 1-year change 3-year change Capi.($)
+9.45%+10.15%+55.65%+1,456.52% 381M
-1.55%+4.55%+97.33%+570.56% 49.78B
+0.17%+1.06%+18.40%+60.93% 26.32B
+0.64%+1.55%-11.60%-36.55% 6.89B
-1.74%+6.93%+1.90%+165.80% 5.96B
+1.37%+0.31%+17.91%+62.83% 3.3B
+2.94%+12.65%-19.73%+2,124.20% 2.91B
+0.26%+7.25%+137.05%+40.71% 2.43B
+14.29%+4.91%+36.77%+45.93% 2.26B
+0.97%+1.95%-14.64%-54.60% 1.85B
Average +2.66%+2.61%+31.90%+443.63% 10.21B
Weighted average by Cap. -0.26%+5.24%+55.58%+370.11%

Financials

2027 *2028 *
Net sales 5.5M 3.92M 3.4M 3.21M 2.92M 5.47M 376M 38.36M 14.82M 191M 14.74M 14.41M 608M 21.25M 15.16M 13.13M 12.41M 11.27M 21.12M 1.45B 148M 57.27M 737M 56.94M 55.67M 2.35B
Net income -23.96M -17.09M -14.81M -14M -12.71M -23.82M -1.64B -167M -64.59M -832M -64.21M -62.79M -2.65B -12.69M -9.05M -7.84M -7.41M -6.73M -12.61M -868M -88.51M -34.2M -440M -34M -33.25M -1.4B
Net Debt -54.74M -39.04M -33.84M -31.98M -29.03M -54.41M -3.75B -382M -148M -1.9B -147M -143M -6.06B -46.27M -33M -28.6M -27.03M -24.54M -46M -3.17B -323M -125M -1.61B -124M -121M -5.12B
Logo Artrya Limited
Artrya Limited is a medical technology company. The Company is engaged in development and commercialization of its patented artificial intelligence (AI) platform that detects, diagnoses, and helps address coronary artery. It partners with clinics receiving chest pain patients to deliver new models of cardiovascular care based on AI. Easily integrate plaque features of high prognostic value into the evaluation of coronary artery disease. Its Artrya Salix is a computed tomography coronary angiography (CCTA) image analysis solution that enables physicians with AI to identify and analyze the extent and type of arterial plaque. This solution uses no external reading teams to validate cardiac scan data, allowing physicians direct control of their AI-supported patient scans. Its Artrya Salix assists physicians in the rapid and convenient analysis of cardiac CT scans to screen patients at risk of heart attack.
Employees
-
Date Price Change Volume
26-09-17 A$3.590 +9.45% 1,045,527
26-09-16 A$3.280 +0.61% 945,059
26-09-15 A$3.260 +1.24% 1,408,743
26-09-14 A$3.220 -1.53% 1,554,181
26-09-11 A$3.270 +0.62% 2,215,227
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.280AUD
Average target price
5.990AUD
Spread / Average Target
+82.62%

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!